Profile data is unavailable for this security.
About the company
Menicon Co., Ltd. is a Japan-based company mainly engaged in operation of contact lens related business and other business. The Company has two business segments. With its subsidiaries, the Contact Lens segment is engaged in manufacture and sales of contact lens, care supplies and other goods. The Others segment is engaged in development and sales of veterinary medical products, decomposition accelerator of rice straw, composting accelerator of livestock excrement, assisted reproductive medicine and products of advanced medical fields, as well as management of contact lens retailer staff training school and provision of temporary staffing service, among others.
- Revenue in JPY (TTM)118.64bn
- Net income in JPY4.84bn
- Incorporated1957
- Employees4.22k
- LocationMenicon Co Ltd3-21-19, Aoi, Naka-kuNAGOYA-SHI 460-0006JapanJPN
- Phone+81 529351515
- Websitehttps://www.menicon.co.jp/
More ▼
Mergers & acquisitions
| Acquired company | 7780:TYO since announced | Transaction value |
|---|---|---|
| PT Oculus Indonesia | 9.06% | -- |
| Oculus visioncare (S) Pte Ltd | 9.06% | -- |
| Oculus (M) Sdn Bhd | 9.06% | -- |
| Dencott Laboratories SA | 6.20% | -- |
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shofu Inc | 37.52bn | 4.46bn | 75.58bn | 1.37k | 16.88 | 1.81 | 18.48 | 2.01 | 125.14 | 125.14 | 1,052.79 | 1,168.62 | 0.7951 | 1.44 | 9.49 | 27,406,870.00 | 9.48 | 6.15 | 10.62 | 7.00 | 59.71 | 57.76 | 11.92 | 8.12 | 2.89 | -- | 0.0048 | 31.84 | 10.74 | 7.08 | 16.59 | 24.93 | 5.03 | 21.94 |
| Intermestic Inc | -100.00bn | -100.00bn | 77.94bn | 1.84k | -- | 7.31 | -- | -- | -- | -- | -- | 348.56 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.10 | -- | 0.494 | -- | 11.12 | -- | 102.26 | -- | -- | -- |
| Nagaileben Co., Ltd. | 16.41bn | 2.82bn | 80.76bn | 511.00 | 25.45 | 1.67 | 33.74 | 4.92 | 88.80 | 88.80 | 516.26 | 1,355.91 | 0.3488 | 1.48 | 3.29 | -- | 6.00 | 7.32 | 6.43 | 7.92 | 42.83 | 44.58 | 17.19 | 19.71 | 10.20 | -- | -- | 57.20 | -4.48 | -0.4484 | -12.53 | -3.91 | -6.53 | 0.00 |
| Eiken Chemical Co Ltd | 39.52bn | 2.33bn | 83.71bn | 757.00 | 33.56 | 1.62 | 17.75 | 2.12 | 64.72 | 64.72 | 1,103.44 | 1,339.12 | 0.6099 | 2.74 | 3.30 | 52,202,110.00 | 3.59 | 8.01 | 4.41 | 10.14 | 41.23 | 45.92 | 5.88 | 11.50 | 2.13 | -- | 0.0608 | 35.45 | -7.44 | 2.29 | -54.08 | -5.24 | 11.66 | 11.20 |
| Japan Lifeline Co., Ltd. | 54.24bn | 7.92bn | 97.35bn | 1.22k | 11.89 | 1.65 | 10.16 | 1.79 | 108.04 | 108.04 | 738.09 | 779.23 | 0.7759 | 1.41 | 4.07 | 44,602,800.00 | 11.33 | 8.63 | 14.02 | 10.88 | 60.32 | 57.28 | 14.60 | 12.28 | 1.62 | -- | 0.0885 | 48.80 | -0.7073 | 2.45 | 9.06 | -0.5446 | 5.40 | 7.69 |
| HOGY MEDICAL CO., LTD. | 29.29bn | 2.08bn | 102.09bn | 1.41k | 52.92 | 1.29 | 15.02 | 3.49 | 85.61 | 85.61 | 1,278.04 | 3,515.34 | 0.2912 | 1.99 | 2.33 | 20,801,850.00 | 2.06 | 4.24 | 2.27 | 4.67 | 32.53 | 39.76 | 7.09 | 11.58 | 3.80 | -- | 0.1621 | 45.68 | 0.3053 | 1.30 | -35.03 | -14.24 | 7.94 | 4.56 |
| Menicon Co Ltd | 118.64bn | 4.84bn | 124.09bn | 4.22k | 26.71 | 1.43 | 9.58 | 1.05 | 60.62 | 60.62 | 1,495.58 | 1,132.00 | 0.6615 | 2.85 | 8.68 | 28,106,370.00 | 2.70 | 4.53 | 3.36 | 5.67 | 53.41 | 52.97 | 4.08 | 5.72 | 1.28 | 109.35 | 0.4583 | 27.12 | 5.44 | 7.51 | -38.48 | 4.88 | 32.61 | 12.30 |
| PHC Holdings Corp | 360.94bn | -6.34bn | 131.02bn | 9.25k | -- | 1.02 | 5.84 | 0.363 | -50.71 | -50.71 | 2,859.74 | 1,013.24 | 0.6587 | 3.48 | 5.67 | 39,042,080.00 | -1.17 | -0.0766 | -1.55 | -0.1164 | 45.47 | 47.71 | -1.78 | -0.1268 | 0.8238 | 0.7074 | 0.6779 | -- | -0.7109 | 13.66 | -300.16 | -- | 16.68 | -- |
| Paramount Bed Holdings Co Ltd | 104.97bn | 7.60bn | 154.94bn | 4.13k | 19.08 | 1.06 | 8.53 | 1.48 | 131.51 | 131.51 | 1,817.75 | 2,368.09 | 0.5947 | 4.54 | 4.66 | 25,441,110.00 | 4.30 | 5.59 | 4.92 | 6.59 | 47.85 | 46.91 | 7.24 | 9.59 | 3.70 | -- | 0.0469 | 36.65 | 7.08 | 5.77 | 15.27 | 9.64 | 16.64 | 5.39 |
Data as of Nov 15 2024. Currency figures normalised to Menicon Co Ltd's reporting currency: Japanese Yen JPY
19.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Global Alpha Capital Management Ltd.as of 16 Feb 2024 | 3.75m | 4.89% |
| Nomura Asset Management Co., Ltd.as of 03 Oct 2024 | 2.26m | 2.95% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 1.75m | 2.28% |
| Asset Management One Co., Ltd.as of 15 Nov 2023 | 1.45m | 1.89% |
| Daiwa Asset Management Co. Ltd.as of 30 Sep 2024 | 1.09m | 1.43% |
| Nikko Asset Management Co., Ltd.as of 04 Oct 2024 | 1.01m | 1.31% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 1.00m | 1.31% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 976.60k | 1.27% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 729.80k | 0.95% |
| Silvercross Investment Management BVas of 31 Oct 2023 | 699.97k | 0.91% |
More ▼
Data from 31 Oct 2023 - 30 Sep 2024Source: FactSet Research Systems Inc.
